UK Clinical Trials Showing Signs Of Recovery But Global Ranking Still Poor

While things are starting to look up for the commercial clinical trial ecosystem in the UK, more progress is needed to improve industry’s confidence in the country as a destination for research, especially revenue-generating Phase III trials.